ClinicalTrials.gg
RecruitingNCT07910500ANK-FNBUpdated Nov 2, 2026

Anterior Nerves of the Knee Block Versus Femoral Nerve Block for Knee Arthroscopy

An interventional study of Anterior Nerves of the Knee (ANK) Block and Femoral Nerve Block in Postoperative Pain, Knee Arthroscopy and Analgesia, sponsored by Van Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Van Training and Research Hospital · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Knee arthroscopy is one of the most common orthopedic procedures, and effective postoperative analgesia is essential for early mobilization and patient comfort. Femoral nerve block provides effective analgesia after knee surgery but can cause quadriceps weakness. The anterior nerves of the knee (ANK) block is a recently described, motor-sparing fascial plane block targeting the sensory nerves of the anterior knee. This prospective, randomized, single-blind study compares ultrasound-guided ANK block with ultrasound-guided femoral nerve block in adult patients undergoing elective knee arthroscopy under spinal anesthesia, with respect to postoperative analgesic consumption, pain scores, intraoperative hemodynamics and time to first mobilization.

Read the detailed description

Adult patients (18-65 years, ASA I-II) scheduled for elective knee arthroscopy under spinal anesthesia will be randomized 1:1 using sealed opaque envelopes to receive either an ultrasound-guided ANK block or an ultrasound-guided femoral nerve block in the block room before surgery. Both blocks are performed with 20 mL of 0.25% bupivacaine (10 mL of 0.5% bupivacaine diluted with 10 mL of 0.9% saline). Sensory and motor block (quadriceps strength, MRC scale) are assessed 20 minutes after the block. All patients then receive standard spinal anesthesia with 12.5 mg of 0.5% hyperbaric bupivacaine without adjuvants. Premedication is standardized (midazolam 1 mg and fentanyl 50 mcg IV). Identical dressings are applied to the groin and knee in all patients to maintain blinding.

Heart rate and blood pressure are recorded at baseline (before spinal anesthesia), skin incision, tourniquet inflation, tourniquet deflation and end of surgery. Postoperative analgesia consists of IV paracetamol and IV tramadol as rescue analgesia, administered by ward staff blinded to group allocation. Pain is assessed with a Visual Analog Scale (0-10) at rest and on movement at 0, 2, 4, 6, 12 and 24 hours postoperatively by an assessor blinded to group allocation. The anesthesiologist performing the block is not blinded. Block-related complications (local anesthetic systemic toxicity, hematoma, infection, falls/knee buckling) are recorded.

02

Conditions studied

  • Postoperative Pain
  • Knee Arthroscopy
  • Analgesia

Browse trials for

Keywords

  • anterior nerves of the knee block
  • femoral nerve block
  • regional anesthesia
  • ultrasound-guided nerve block
  • spinal anesthesia
  • ANK block
03

In context

Pain, Postoperative

5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.

This study's planned enrollment of 70 is close to the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Van Training and Research Hospital is the lead sponsor of 8 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

-

Inclusion Criteria:

  • Age 18 to 65 years
  • (ASA) physical status I-II
  • Scheduled for elective knee arthroscopy
  • Surgery performed under spinal anesthesia
  • Written

Exclusion Criteria:

  • Refusal to participate
  • Allergy to local anesthetics or study analgesics
  • Infection at the block site
  • Coagulopathy or anticoagulant therapy
  • Pre-existing neurological deficit or motor weakness in the operated limb
  • Chronic pain or regular opioid use
  • Inability to cooperate with pain assessment
  • Emergency surgery
  • to spinal anesthesia

Exclusion Criteria:

-

Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    ANK Block

    Patients receive an ultrasound-guided anterior nerves of the knee (ANK) block with 20 mL of 0.25% bupivacaine before spinal anesthesia for knee arthroscopy.

    Procedure: Anterior Nerves of the Knee (ANK) Block

  • Active comparator
    Femoral Nerve Block

    Patients receive an ultrasound-guided femoral nerve block with 20 mL of 0.25% bupivacaine before spinal anesthesia for knee arthroscopy.

    Procedure: Femoral Nerve Block

Interventions

  • ProcedureAnterior Nerves of the Knee (ANK) Block

    Ultrasound-guided anterior nerves of the knee (ANK) block performed in the block room before spinal anesthesia with 20 mL of 0.25% bupivacaine (10 mL of 0.5% bupivacaine diluted with 10 mL of 0.9% saline).

    Also known as: ANK block

  • ProcedureFemoral Nerve Block

    Ultrasound-guided femoral nerve block performed in the block room before spinal anesthesia with 20 mL of 0.25% bupivacaine (10 mL of 0.5% bupivacaine diluted with 10 mL of 0.9% saline).

06

What researchers measure

Primary outcomes

  1. Total Postoperative Tramadol Consumption

    Total amount of intravenous tramadol (mg) administered as rescue analgesia during the first 24 hours after the end of surgery.

    Time frame: 24 hours after surgery

  2. Pain Score at Rest

    Pain intensity at rest assessed with a Visual Analog Scale (VAS) from 0 (no pain) to 10 (worst imaginable pain) by an assessor blinded to group allocation.

    Time frame: 0, 2, 4, 6, 12 and 24 hours after surgery

  3. Pain Score on Movement

    Pain intensity on movement assessed with a Visual Analog Scale (VAS) from 0 (no pain) to 10 (worst imaginable pain) by an assessor blinded to group allocation.

    Time frame: 0, 2, 4, 6, 12 and 24 hours after surgery

Secondary outcomes

  1. Time to First Rescue Analgesic

    Time (minutes) from the end of surgery to the first administration of a rescue analgesic (tramadol or paracetamol, whichever is first). Patients who require no analgesic are censored at 24 hours.

    Time frame: 24 hours after surgery

  2. Total Postoperative Paracetamol Consumption

    Total amount of intravenous paracetamol (mg) administered during the first 24 hours after the end of surgery.

    Time frame: 24 hours after surgery

  3. Intraoperative Heart Rate

    Heart rate (beats/min) recorded at baseline (before spinal anesthesia), skin incision, tourniquet inflation, tourniquet deflation and end of surgery.

    Time frame: From baseline (before spinal anesthesia) to the end of surgery

  4. Intraoperative Mean Arterial Pressure

    Mean arterial pressure (mmHg) recorded at baseline (before spinal anesthesia), skin incision, tourniquet inflation, tourniquet deflation and end of surgery.

    Time frame: From baseline (before spinal anesthesia) to the end of surgery

  5. Time to First Mobilization

    Time (hours) from the end of surgery to the first safe ambulation.

    Time frame: Up to 48 hours after surgery

  6. Quadriceps Muscle Strength

    Quadriceps muscle strength of the operated limb assessed with the Medical Research Council (MRC) scale from 0 (no contraction) to 5 (normal strength).

    Time frame: 20 minutes after block

  7. Incidence of Block-Related Complications

    Number of participants with local anesthetic systemic toxicity, hematoma or infection at the injection site, or falls/knee buckling during mobilization.

    Time frame: 24 hours after surgery

07

Study locations

1 of 1 sites recruiting
  • University of Health Sciences, Van Training and Research Hospital
    Van, Turkey (Türkiye)
    Recruiting
    • Ömer Türk, MD · Contactomer_turk@hotmail.com · +90 506 979 41 95
    • Ömer Türk, MD · Principal investigator
    • Cemal Kaçar, MD · Sub investigator
08

References and documents

Publications

  • Chen B, Tan M, Li Q, Wang S, Chen D, Zhao M, Cao J. Application of ultrasound-guided single femoral triangle and adductor canal block in arthroscopic knee surgery: a prospective, double-blind, randomized clinical study. BMC Anesthesiol. 2024 May 23;24(1):182. doi: 10.1186/s12871-024-02555-0. PubMed 38783177 ↗
  • Balaban O, Isik R, Eman A, Karacan K, Nas K. Anterior nerves of the knee (ANK) block: A novel motor sparing fascial plane block for analgesia of the knee: Observational cohort study. Medicine (Baltimore). 2025 Dec 5;104(49):e46035. doi: 10.1097/MD.0000000000046035. PubMed 41366903 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared publicly. De-identified data may be made available by the corresponding author upon reasonable request.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Mar 2027, 4 months after the start.

Of 2,089 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 4 months is below that.

Counting every sponsor, half of 2,102 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 26, 2026
First posted
Nov 2, 2026
StartActual
Oct 19, 2026
Primary completionEst.
Mar 15, 2027
CompletionEst.
Mar 15, 2027
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07910500
Lead sponsor
Van Training and Research Hospital
Responsible party
Ömer TÜRK (Specialist in Anesthesiology and Reanimation, Van Training and Research Hospital) — Principal investigator
First posted
Nov 2, 2026
Start date
Oct 19, 2026
Primary completion
Mar 15, 2027 (estimated)
Completion
Mar 15, 2027 (estimated)
Last update
Nov 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion